186 related articles for article (PubMed ID: 33635825)
1. Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study.
Chifu I; Gerstl A; Lengenfelder B; Schmitt D; Nagler N; Fassnacht M; Weismann D
Eur J Endocrinol; 2021 May; 184(5):647-655. PubMed ID: 33635825
[TBL] [Abstract][Full Text] [Related]
2. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection.
Mohmand HK; Issa D; Ahmad Z; Cappuccio JD; Kouides RW; Sterns RH
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1110-7. PubMed ID: 17913972
[TBL] [Abstract][Full Text] [Related]
3. Continuous Versus Bolus Infusion of Hypertonic Saline in the Treatment of Symptomatic Hyponatremia Caused by SIAD.
Garrahy A; Dineen R; Hannon AM; Cuesta M; Tormey W; Sherlock M; Thompson CJ
J Clin Endocrinol Metab; 2019 Sep; 104(9):3595-3602. PubMed ID: 30882872
[TBL] [Abstract][Full Text] [Related]
4. Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.
Baek SH; Jo YH; Ahn S; Medina-Liabres K; Oh YK; Lee JB; Kim S
JAMA Intern Med; 2021 Jan; 181(1):81-92. PubMed ID: 33104189
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of Hyponatremia: A Review.
Adrogué HJ; Tucker BM; Madias NE
JAMA; 2022 Jul; 328(3):280-291. PubMed ID: 35852524
[TBL] [Abstract][Full Text] [Related]
6. A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis.
Aratani S; Hara M; Nagahama M; Taki F; Futatsuyama M; Tsuruoka S; Komatsu Y
BMC Nephrol; 2017 Oct; 18(1):316. PubMed ID: 29047375
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial).
Lee A; Jo YH; Kim K; Ahn S; Oh YK; Lee H; Shin J; Chin HJ; Na KY; Lee JB; Baek SH; Kim S
Trials; 2017 Mar; 18(1):147. PubMed ID: 28356136
[TBL] [Abstract][Full Text] [Related]
8. Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
Pelouto A; Refardt JC; Christ-Crain M; Zandbergen AAM; Hoorn EJ
Eur J Endocrinol; 2023 Mar; 188(3):322-330. PubMed ID: 36881992
[TBL] [Abstract][Full Text] [Related]
9. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Sood L; Sterns RH; Hix JK; Silver SM; Chen L
Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
[TBL] [Abstract][Full Text] [Related]
11. Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy.
Sarnaik AP; Meert K; Hackbarth R; Fleischmann L
Crit Care Med; 1991 Jun; 19(6):758-62. PubMed ID: 2055051
[TBL] [Abstract][Full Text] [Related]
12. Conivaptan for hyponatremia in the neurocritical care unit.
Wright WL; Asbury WH; Gilmore JL; Samuels OB
Neurocrit Care; 2009; 11(1):6-13. PubMed ID: 19003543
[TBL] [Abstract][Full Text] [Related]
13. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study.
Burst V; Grundmann F; Kubacki T; Greenberg A; Becker I; Rudolf D; Verbalis J
Am J Nephrol; 2017; 45(5):420-430. PubMed ID: 28419981
[TBL] [Abstract][Full Text] [Related]
14. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.
Murphy T; Dhar R; Diringer M
Neurocrit Care; 2009; 11(1):14-9. PubMed ID: 19123060
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a protocol for hypertonic saline administration in acute euvolemic symptomatic hyponatremia: A prospective observational trial.
Bhaskar E; Kumar B; Ramalakshmi S
Indian J Crit Care Med; 2010 Oct; 14(4):170-4. PubMed ID: 21572746
[TBL] [Abstract][Full Text] [Related]
16. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia.
Woo CH; Rao VA; Sheridan W; Flint AC
Neurocrit Care; 2009; 11(2):228-34. PubMed ID: 19533046
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline.
Simma B; Burger R; Falk M; Sacher P; Fanconi S
Crit Care Med; 1998 Jul; 26(7):1265-70. PubMed ID: 9671379
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Hyponatremia in Patients with Acute Neurological Injury.
Human T; Cook AM; Anger B; Bledsoe K; Castle A; Deen D; Gibbs H; Lesch C; Liang N; McAllen K; Morrison C; Parker D; Rowe AS; Rhoney D; Sangha K; Santayana E; Taylor S; Tesoro E; Brophy G
Neurocrit Care; 2017 Oct; 27(2):242-248. PubMed ID: 28054290
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Kim Y; Lee N; Lee KE; Gwak HS
Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
[TBL] [Abstract][Full Text] [Related]
20. Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.
Issa VS; Bacal F; Mangini S; Carneiro RM; Azevedo CH; Chizzola PR; Ferreira SM; Bocchi EA
Arq Bras Cardiol; 2007 Oct; 89(4):251-5. PubMed ID: 17992382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
